KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Johnson & Johnson (JNJ) EBIAT (2016 - 2026)

Johnson & Johnson's EBIAT history spans 18 years, with the latest figure at $5.2 billion for Q1 2026.

  • On a quarterly basis, EBIAT fell 52.4% to $5.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $21.0 billion, a 3.53% decrease, with the full-year FY2025 number at $26.8 billion, up 90.56% from a year prior.
  • EBIAT hit $5.2 billion in Q1 2026 for Johnson & Johnson, up from $5.1 billion in the prior quarter.
  • Over the last five years, EBIAT for JNJ hit a ceiling of $11.0 billion in Q1 2025 and a floor of -$491.0 million in Q2 2023.
  • Historically, EBIAT has averaged $4.5 billion across 5 years, with a median of $4.5 billion in 2022.
  • Biggest five-year swings in EBIAT: plummeted 110.74% in 2023 and later skyrocketed 762.93% in 2024.
  • Tracing JNJ's EBIAT over 5 years: stood at $4.5 billion in 2022, then decreased by 9.17% to $4.0 billion in 2023, then dropped by 15.26% to $3.4 billion in 2024, then surged by 49.11% to $5.1 billion in 2025, then increased by 2.33% to $5.2 billion in 2026.
  • Business Quant data shows EBIAT for JNJ at $5.2 billion in Q1 2026, $5.1 billion in Q4 2025, and $5.2 billion in Q3 2025.